Details

Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca

Metadata and links for an archived snapshot.

Source
Public Health Agency of Canada
Date
Mar 11, 2026 · edition #7
Timestamp
2026-03-11T10:45:05.444Z
Language
en
Original URL
https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-medicago-covid-19-vaccine/summary-march-11-2022.html
Replay URL
https://replay.healtharchive.ca/job-7/20260311104505/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-medicago-covid-19-vaccine/summary-march-11-2022.html#ha_snapshot=787679
ID
787679
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

ViewView diffRaw HTML ↗Metadata JSON ↗CiteReport issueAll snapshots

Other snapshots

Archived page preview